Development of a fundamental technology, which is applicable to drug development and therapeutic applications through analysis of sulfated glycosaminoglycan chains
通过分析硫酸糖胺聚糖链开发适用于药物开发和治疗应用的基础技术
基本信息
- 批准号:16390026
- 负责人:
- 金额:$ 9.54万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
(1)It has been demonstrated that congenital human spondyloepiphysial dysplasia is caused by a mutation of the chondroitin 6-O-sulfotransferase 1 gene.(2)The nematode ortholog PAR2.4 of the human chondroitin polymerizing factor (ChPF) that is involved in the biosynthesis of chondroitin has been cloned. Furthermore it was found that downregulation of PAR2.4 by RNAi resulted in the cytokinesis defect during embryonic development of the nematode, which resembled the defect caused by RNAi of chondroitin synthase, indicating the essential role of PAR2.4 in the synthesis of chondroitin as well as the critical role of chondroitin in cytokinesis.(3)Various biological activities have been demonstrated for CS/DS hybrid chains isolated from shark skin, suggesting a possible therapeutic applications of the CS/DS chains.(4)It has been proved that the neurite outgrowth promoting activity of CS/DS chains from embryonic mouse brains is exhibited by molecular interactions with a growth factor pleiotrophin. Sulfated decasaccharides derived from the functional domains have also been isolated and sequenced.(5)A monoclonal antibody specific for dermatan sulfate was developed using an oversulfated dermatan sulfate preparation with a potent neurite outgrowth promoting activity, which was purified from marine ascidian. The antibody apecifically bound to mouse hippocampal neurons, and inhibited the neurite outgrowth promoting activity, which was exhibited by the DS preparation used as an immunogen.(6)Conventionally herpes simplex virus (HSV-1 and HSV-2) have been considered to infect cells through attachment to heparan sulfate chains on cell surface. In this study it has been demonstrated the infection is more strongly inhibited by CS-E than heparin. Furthermore the CS-E structure has beendemonstrated on cell surface. There results suggest that the viruses use CS-E more efficiently than heparan sulfate for their infection.
(1)It已经证明先天性人脊椎骨骺发育不良是由软骨素6-O-磺基转移酶1基因突变引起的。(2)已克隆了参与软骨素生物合成的人软骨素聚合因子(ChPF)的线虫直系同源物PAR 2.4。进一步发现,通过RNAi下调PAR 2.4导致线虫胚胎发育过程中的胞质分裂缺陷,这类似于软骨素合酶的RNAi引起的缺陷,表明PAR 2.4在软骨素合成中的重要作用以及软骨素在胞质分裂中的关键作用。(3)从鲨鱼皮中分离的CS/DS杂合链具有多种生物学活性,提示CS/DS杂合链可能具有治疗应用价值。(4)It已经证明,来自胚胎小鼠脑的CS/DS链的神经突生长促进活性是通过与生长因子多效生长因子的分子相互作用来表现的。硫酸化十糖衍生的功能结构域也已被分离和测序。(5)A使用从海洋海鞘中纯化的具有有效的神经突生长促进活性的过硫酸化硫酸皮肤素制剂,开发了对硫酸皮肤素特异的单克隆抗体。抗体apecipirin与小鼠海马神经元结合,并抑制神经突生长促进活性,这是由用作免疫原的DS制剂表现出来的。(6)以往认为单纯疱疹病毒(HSV-1、HSV-2)通过附着于细胞表面的硫酸乙酰肝素链而感染细胞。在这项研究中,已经证明CS-E比肝素对感染的抑制作用更强。此外,在细胞表面也发现了CS-E结构。这些结果表明,病毒使用CS-E比硫酸乙酰肝素更有效地进行感染。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nematode chondroitin polymerizing factor showing cell-/organ-specific expression is indispensable for chondroitin synthesis and embryonic cell division
- DOI:10.1074/jbc.m409615200
- 发表时间:2004-12-17
- 期刊:
- 影响因子:4.8
- 作者:Izumikawa, T;Kitagawa, H;Sugahara, K
- 通讯作者:Sugahara, K
Demonstration of the pleiotrophin-binding oligosaccharide sequences isolated from chondroitin sulfate/dermatan sulfate hybrid chains of embryonic pig brains
- DOI:10.1074/jbc.m507304200
- 发表时间:2005-10-21
- 期刊:
- 影响因子:4.8
- 作者:Bao, XF;Muramatsu, T;Sugahara, K
- 通讯作者:Sugahara, K
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUGAHARA Kazuyuki其他文献
SUGAHARA Kazuyuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUGAHARA Kazuyuki', 18)}}的其他基金
Molecular mechanism for roles of chondroitin sulfate in tumor metastasis
硫酸软骨素在肿瘤转移中作用的分子机制
- 批准号:
23390016 - 财政年份:2011
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanism of proteoglycan signalings
蛋白多糖信号传导的分子机制
- 批准号:
20390019 - 财政年份:2008
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional analysis of glycosaminoglycans as a potential drug target and the decoding of carbohydrate signaling of the functional domains
糖胺聚糖作为潜在药物靶标的功能分析以及功能域碳水化合物信号的解码
- 批准号:
18390030 - 财政年份:2006
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Scenario of the biosynthesis of glycosaminoglycans
糖胺聚糖生物合成的场景
- 批准号:
14082207 - 财政年份:2002
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Analysis of the biosynthetic mechanism and functions of glycosaminogycans by manipulating the genes encoding biosynthetic enzymes.
通过操纵编码生物合成酶的基因来分析糖胺聚糖的生物合成机制和功能。
- 批准号:
13470493 - 财政年份:2001
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of the haparan sulfate-based anti-cancer drugs
硫酸乙酰肝素抗癌药物的研制
- 批准号:
12557214 - 财政年份:2000
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a universal sequencing method for sulfated glycosaminoglycans
硫酸化糖胺聚糖通用测序方法的开发
- 批准号:
09558082 - 财政年份:1997
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
神経突起伸長と血管新生におけるグリコサミノグリカン糖鎖の分子認識
神经突生长和血管生成中糖胺聚糖糖链的分子识别
- 批准号:
09470509 - 财政年份:1997
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Studies on the Biosynthetic Mechanism of Bioactive Sulfated Glycosaminoglycans
生物活性硫酸化糖胺聚糖的生物合成机制研究
- 批准号:
08044327 - 财政年份:1996
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for international Scientific Research
Structure and Biosynthesis of Carbohydrate-Protein Linkage Region of Dermatan Sulfate and Chondroitin Sulfate
硫酸皮肤素和硫酸软骨素碳水化合物-蛋白质连接区的结构和生物合成
- 批准号:
06808061 - 财政年份:1994
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Clarification of dermatan sulfate elongation mechanism that promotes onset and progress of atherosclerosis by cadmium
阐明镉促进动脉粥样硬化发生和进展的硫酸皮肤素伸长机制
- 批准号:
19K19418 - 财政年份:2019
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Integrated understanding of dermatan sulfate through uncovering pathophysiology of musculocontractural Ehlers-Danlos syndrome
通过揭示肌肉收缩性埃勒斯-当洛斯综合征的病理生理学来全面了解硫酸皮肤素
- 批准号:
19H03616 - 财政年份:2019
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The loss of the dermatan sulfate proteoglycan decorin differentially affects cytokine and syndecan-1 expression during allergic inflammation
硫酸皮肤素蛋白多糖核心蛋白聚糖的缺失对过敏性炎症期间细胞因子和 Syndecan-1 的表达产生不同影响
- 批准号:
203353484 - 财政年份:2011
- 资助金额:
$ 9.54万 - 项目类别:
Research Grants
Study on the physiological and pathological function of highly-sufated chondroitin/dermatan sulfate
高硫酸化软骨素/硫酸皮肤素的生理病理功能研究
- 批准号:
23570175 - 财政年份:2011
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MULTISTAGE MS DISSOCIATION OF CHONDROITIN/DERMATAN SULFATE OLIGOSACCHARIDES
软骨素/硫酸皮肤素低聚糖的多级 MS 解离
- 批准号:
8365533 - 财政年份:2011
- 资助金额:
$ 9.54万 - 项目类别:
MULTISTAGE MS DISSOCIATION OF CHONDROITIN/DERMATAN SULFATE OLIGOSACCHARIDES
软骨素/硫酸皮肤素低聚糖的多级 MS 解离
- 批准号:
8170900 - 财政年份:2010
- 资助金额:
$ 9.54万 - 项目类别:
Synthetic and biological studies of chondroitin sulfate and dermatan sulfate partial structure which potentially associate with neurite growth-promoting activity.
硫酸软骨素和硫酸皮肤素部分结构的合成和生物学研究,可能与神经突生长促进活性相关。
- 批准号:
21710233 - 财政年份:2009
- 资助金额:
$ 9.54万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
MULTISTAGE MS DISSOCIATION OF CHONDROITIN/DERMATAN SULFATE OLIGOSACCHARIDES
软骨素/硫酸皮肤素低聚糖的多级 MS 解离
- 批准号:
7955930 - 财政年份:2009
- 资助金额:
$ 9.54万 - 项目类别:
Dermatan sulfate and its role in tissue repair
硫酸皮肤素及其在组织修复中的作用
- 批准号:
7405689 - 财政年份:2008
- 资助金额:
$ 9.54万 - 项目类别:
Dermatan sulfate and its role in tissue repair
硫酸皮肤素及其在组织修复中的作用
- 批准号:
7612708 - 财政年份:2008
- 资助金额:
$ 9.54万 - 项目类别: